IL6 and esophageal squamous cell carcinoma: Fan et al. demonstrated on an ESCC rat model induced with N-nitroso-N-methylbenzylamine (NMBzA) that metformin reduced esophageal inflammation and carcinogenesis by suppressing iNOS, COX-2 and IL-6 expressions.